CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity.
Fagg
G E
GE
CIBA-GEIGY Ltd., Basel, Switzerland.
Olpe
H R
HR
Schmutz
M
M
Pozza
M F
MF
van Riezen
H
H
Bittiger
H
H
Angst
C
C
Brundish
D
D
Allgeier
H
H
Heckendorn
R
R
D015763:2-Amino-5-phosphonovalerate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D000284:Administration, Oral; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000494:pharmacology*; D001667:Binding, Competitive; D007700:Kinetics; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000927:Anticonvulsants; D016194:Receptors, N-Methyl-D-Aspartate; C064540:CGP 39551; C064539:2-amino-4-methyl-5-phosphono-3-pentenoic acid; D015763:2-Amino-5-phosphonovalerate